Progressive 13-cis-retinoic acid dosage in the treatment of oral leukoplakia

Hong, 1991, The biology and chemoprevention of head and neck cancer, Educational Book, 99 Hong, 1986, 13-cis-retinoic acid in the treatment of oral leukoplakia, N Engl J Med, 315, 1501, 10.1056/NEJM198612113152401 Slaughter, 1953, “Field cancerization” in oral stratified squamous epithelium: clinical implications of multicentric origin, Cancer, 6, 963, 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q Strong, 1984, Field cancerization in the aerodigestive tract—its etiology, manifestation, and significance, J Otolaryngol, 13, 1 Lippman, 1990, Low-dose 13-cis-retinoic acid (13cRA) maintains remission in oral premalignancy: more effective than Beta-carotene in randomized trial, 9, A225 Stich, 1988, Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-caroten and with beta-carotene plus vitamin A, Int J Cancer, 42, 195, 10.1002/ijc.2910420209 Bollag, 1990, Retinoids and interferon—a new promising combination, 56 Malone, 1989, Chemioprevention strategies utilizing combinations of inhibitors of carcinogenesis, J Natl Cancer Inst, 81, 824, 10.1093/jnci/81.11.824 Pluygers, 1991, Markers of promotion in carcinogenesis as intermediate endpoints for monitoring the efficacy of cancer prevention, CM Cancer, 219 Malone, 1991, Ongoing preclinical and initial clinical studies in chemoprevention, CM Cancer, 111 Toma, 1991, In vitro effects of beta-carotene on human oral keratinocytes from precancerous lesions and squamous carcinoma, Anticancer Drugs, 2, 581, 10.1097/00001813-199112000-00009